|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Cash and cash equivalents | ||||||||
| Grants receivable | ||||||||
| Due from affiliates | ||||||||
| Prepaid expenses and other current assets | ||||||||
| Total current assets | ||||||||
| Property and equipment, net | ||||||||
| Operating lease right-of-use asset, net | ||||||||
| Finance lease right-of-use asset, net | ||||||||
| Income tax receivable | ||||||||
| Tax Receivable | ||||||||
| Total assets | ||||||||
| LIABILITIES AND EQUITY | ||||||||
| Accounts payable | ||||||||
| Due to affiliates | ||||||||
| Nonrelated Party | ||||||||
| Related Party | ||||||||
| Total due to affiliates | ||||||||
| Operating lease liabilities – Current | ||||||||
| SAFE Liability | ||||||||
| Finance lease liabilities – Current | ||||||||
| Total current Liabilities | ||||||||
| Deferred grant reimbursement | ||||||||
| Warrant Liability | ||||||||
| Operating lease liabilities - Long term | ||||||||
| Finance lease liabilities - Long term | ||||||||
| Total liabilities | ||||||||
| Stockholders’ Equity: | ||||||||
| Common shares, 100,000,000 authorized shares at $0.000001; 9,281,359 and 8,406,681 shares issued and outstanding as of June 30, 2026, and December 31, 2025, respectively | ||||||||
| Additional Paid-in-capital | ||||||||
| Accumulated deficit | ||||||||
| Total equity | ||||||||
| Total liabilities and equity |
Loading...
